Podcasts about HIV

Ria Spencer, Mindy Myers and Josh Connors share stories about learning to feel at home in your body.

A new center for the study of chronic infectious diseases aims to develop treatments for illnesses like Valley fever, tuberculosis, HIV, and Long COVID that disproportionately affect South Texas communities. Led by Dr. Barbara Taylor, the center seeks to attract top researchers and serve as a hub for clinical trials and community-focused care.

Epstein scandal highlights how women and girls are silenced: UN Human Rights chief Fears grow for Afghan civilians after reported Pakistan air strikesDenmark eradicates mother-to-child transmission of syphilis, HIV

From a volunteer-run initiative in the 1980s to a regional continuum of care in 2026: On this episode of Discover Lafayette, we sit down with Claude Martin, CEO of AcadianaCares, to talk about what it looks like when a community builds an institution out of necessity, and then keeps rebuilding it for four decades. AcadianaCares began (originally as “Lafayette CARES”) in 1985, during the earliest, scariest years of the HIV/AIDS epidemic, when fear and stigma shut down many traditional systems of response. “CARES” stood for “Concern for AIDS Relief, Education and Support.” Claude remembers those first years in deeply personal terms: “I got involved with this work, HIV work in the early 80s when our community started to get sick.” He describes a time when an HIV diagnosis in Louisiana carried a terrifying prognosis saying, “the life expectancy was about nine months.” The uncertainty felt like a public-health free fall. When we talk about how frightening those early days were, Claude agrees without hesitation: “Very similar to the fear and confusion many of us felt during COVID. Who's going to get it? and what do we do now?” Claude explains that what became AcadianaCares wasn't a government-created program; it was community members stepping in when institutions froze. “It was a groundswell of people saying, I have to do something. We have to do something.” For years, it ran on sheer willpower. “We were volunteers, running it out of our houses. We all had full-time jobs.” Claude's own job then was far from nonprofit administration as he worked as a landscaper. And while the organization was being built, people were dying. Claude doesn't sanitize that reality. “Sometimes they came to a couple of meetings and then they were in the hospital; within a month they were dead. They were gone.” In those first ten years, he says, “We really were concentrating on helping people to die. We were there.” He describes practical, human-scale solutions built by ordinary people: a hotline routed into volunteers' homes, partnerships for training, and a “Buddy program” where volunteers went into homes to help with the basic tasks of living: cleaning an apartment, getting to appointments, answering desperate late-night questions from people who felt helpless. From there, the story becomes one of evolution, not away from HIV care, but outward from it. Claude explains that in the early 2000s, AcadianaCares started asking a different question: if HIV is the core mission, what are the destabilizing forces that make people more vulnerable in the first place? In his words: “Mental illness, homelessness, substance abuse are three of the big areas that really do destabilize people's lives.” That mindset shaped the modern AcadianaCares model: a system designed so that someone can enter through one doorway to have access to housing, clinic, and recovery, and then be “wrapped around” with the rest. The medical reality has changed — and AcadianaCares is trying to reach the whole community Claude also walks us through the medical transformation he's witnessed across the decades. “The pharmaceutical industry has developed all of these medications so that now life expectancy is open ended.” He explains how viral load suppression changes both individual health and transmission risk. When treatment is working, people are no longer infectious. He points to PrEP as a powerful prevention tool: “PrEP is about 99%” effective in preventing acquisition. The goal he lays out is ambitious and clear: get people living with HIV to an undetectable viral load and get people at risk onto PrEP. “Conceivably, we will get to the point where we have no new infections.” Claude shares the regional scope, then and now. He remembers: “There were 11 people in Lafayette Parish that were living with HIV in 85.” Today, he says, “we have 2000 people that are living with HIV in our region,” with about 75 to 100 new infections every year in the seven parish area. Expansion on the northside: “whole-person care in one place” We also discuss AcadianaCares’ expansion of clinical services on Lafayette's northside. Claude explains that the clinic model exists because they were seeing people newly diagnosed with HIV struggling to get into care quickly. “We were having a really hard time getting people into care once we found out that they were positive.” So they built a system where patients could be seen and started on care faster. AcadianaCares purchased and renovated Pride Plaza at Willow and Pierce, turning it into a primary care clinic open to the public. The clinic has a staff of 32 in its 8,900 square-foot space offers a full spectrum of primary care and mental health services available to both insured and non-insured patients. Dr. Clinton Young is at the clinic specializing in sleep medicine and complex sleep-related disorders. Moving clinic services into Pride Plaza also created room on the main campus for expanded substance-abuse programming. AcadianaCares developed Seasons of Serenity (SOS), a network of residential, outpatient, and sober living recovery programs. Clients in SOS transition from dependency to self-sufficiency through structured phases in a safe and caring environment that is free from discrimination. AcadianaCares celebrating its 40th anniversary and opening of the new Primary Care Mental Care and Pharmacy in February 2026. In our conversation, Claude describes the wraparound approach inside the clinic, not just medical appointments, but navigation help: “Our clinic patients have access to navigators who help them apply for insurance… everything from food stamps to finding other agencies.” He contrasts that with many healthcare settings: “A lot of people go to a provider, but they don't have the social services support or the wraparound support.” The MLK campus: housing + recovery, built over time One of the most substantive parts of our conversation is Claude's description of the Acadiana CARES campus on Martin Luther King Jr. Drive in North Lafayette: housing and recovery programs built through long-term planning, grants, and renovation. The site is located at 809 Martin Luther King Jr. Dr. in North Lafayette. “We have housing there and about 80 people live on the property.” The site originally housed the Lafayette Guest House, formerly a 206-bed nursing facility with an inpatient psychiatric hospital, Oceans Behavior Healthcare, was donated to AcadianaCares by its owners, Jerrine Harrell, Donna McPherson, and John Wright. The owners made the decision to donate the property, valued at approximately $3.5 million, in order to do something good for the community and also be able to claim a charitable donation on taxes. Catholic Charities of Acadiana’s Kim Boudreaux James is the niece of Wright and she helped identify AcadianaCares as the best fit for the donation. (For a comprehensive story of the background of this donation and how it transformed AcadianaCares, see https://theind.com/articles/842/. ) He walks through the arc of development: a major donated property, then years of grants and fundraising to renovate and convert spaces into apartments, and then major investments in addiction treatment. He explains that their Seasons of recovery program now offers “the whole continuum of care,” describing transitions from detox, to a 28-day program, to a 90-day residential program, then outpatient services, and supportive apartment options designed to help people stabilize, work, save money, and re-enter independent life. Claude shares one of the concrete, practical details people often want to know: the outpatient apartment option is “$416” and includes “three meals a day, seven days a week.” He explains the program design goal plainly: “in six months, you ought to be able to save enough money to be independent.” AcadianaCares’ Seasons of Serenity receive referrals statewide: “We get referrals from all over the state,” and adds, “we get probably 7 to 10 referrals a day.” The reality is capacity: “All of our programs are usually at capacity.” Growth that still comes back to one measuring stick Claude has led AcadianaCares through extraordinary growth. He recalls the first state grant: “$34,000.” Today, he says, “our board just approved a $34 million budget.” He notes scale: “We have about 100 employees here, and we help an average of 4000 people a year.” In 2025, 2,495 unique patients received care through its wellness clinic. Its reach is across 25 zip codes in Lafayette, Acadiana, Evangeline, Iberia, St. Landry, St. Martin, and Vermilion parishes. Claude Martin joined AcadianaCares in 1998, after serving as an original volunteer in its early days. “I felt called to do the work. In the early 90s, I went back to school and got a graduate degree in rehabilitation therapy. All my work was focused on getting people living with HIV and having that treated as the same thing that’s a head injury or a substance abuse issue or a mental health issue that would debilitate someone. That degree is designed to help as a life changing experience. to move them through that process and get them back into this life.” But one of the most telling moments in our conversation is his personal standard for quality and dignity. The question he asks himself when planning services and facilities: “Would I let my mother or my sister receive services here?” He connects that directly to the mission: bringing high-quality care to people who often don't have choices, and who may have been neglected for years. Advice for families facing addiction Near the end, Claude offers direct advice to families navigating substance use disorder. His first recommendation is simple and specific: “Join an Al-Anon group.” He explains why: “It's realizing that it's a family disease,” and stresses that the work includes shifting attention toward self-care: “take the focus off of the alcoholic and look at taking care of yourself.” And yes — he shows standard poodles Claude also shares a surprising personal and fun detail that gives listeners as we wound down the interview: “I show dogs. I breed standard poodles.” He competes nationally, and he says, “We won at the nationals last year; Tallulah won the best standard poodle.” It's a reminder that even people carrying enormous community responsibility have a life and identity beyond the mission, and sometimes a very competitive hobby. Claude Martin’s young standard poodle, Talulah, being shown by handler, Kay Peiser, at the Poodle Club of America’s 2025 nationals competition. She won “Best Standard Poodle.” Connect with AcadianaCares Main Office: (337) 233-2437AcadianaCares : (337) 704-0787Pharmacy: (337) 216-1013Locations: 809 Martin Luther King Jr. Drive, Lafayette, and 850 North Pierce Street (Pride Plaza Clinic / Pharmacy area), Lafayette For more information, visit https://www.acadianacares.org/

Matthew Bannister onMartyn Butler who was a central figure in the UK's early response to HIV and AIDS. He was a co-founder of the Terrence Higgins Trust and gave his own home phone number as a helpline.Allan Massie, the Scottish author and critic whose hero was Sir Walter Scott. Sir Ian Rankin pays tribute. Professor Nicola Fear, the epidemiologist who studied the effects on military personnel of serving in the Iraq War and Afghanistan.Willie Colón, the American trombonist who was inspired by his Puerto Rican heritage to create salsa music.Interviewee: Tony Whitehead Interviewee: Sir Ian Rankin Interviewee: Professor Sir Simon Wessely Interviewee: Garth CartwrightProducer: Gareth Nelson-Davies Assistant Producer: Ribika Moktan Editor: Glyn TansleyArchive used: Martyn Butler seminar recording, Terrence Higgins Trust, THT YouTube channel, uploaded 26/06/2022; Terrence Higgins Trust actuality recording, Week In Week Out, BBC Wales, 29/10/1985; News report, BBC News, 08/01/1987; Advert: Iceberg, Department of Health and Social Security, Dir Nicolas Roeg, Voiceover: John Hurt, 1987; Allan Massie, The Book Programme: First Novels, BBC Two, 11/02/1978; Allan Massie interview, France Politics, Writers Revealed, BBC Radio 4, 06/07/1992; Allan Massie interview, General Election Report, BBC News, 10/04/1997; Nicola Fear, The Fear Factor: life as a military epidemiologist, King's College London, uploaded to YouTube on 23/04/2018; Iraq War news report, BBC News, 31/03/2009; Afghanistan News Report, BBC News, 27/10/2014; Willie Colon interview, Latin Music USA, BBC Four, 05/02/2010;

We hear from a Mexican city in Sinaloa state where one of the big drug cartels is locked in its own civil war. Our correspondent Quentin Sommerville visited the state capital, Culiacán, where he witnessed scenes of brutal violence that have brought pain and terror to residents. Also: Cuba says its coastguard has killed four people on board a US-registered speedboat, in an exchange of fire off the Cuban coast. It said those on the boat were Cubans, living in the US, with a history of violent activity - and "terrorist" intentions. The American Secretary of State, Marco Rubio, called the shootout "highly unusual" and said the US would conduct its own investigation into the incident and not rely on the Cuban version of events. A British clinical trial on more than 500 people across 15 countries found that a new tablet to treat HIV - which combines two current treatments - is highly effective at keeping the virus suppressed. A BBC Eye investigation has revealed that Nepal's top police officer gave the order allowing the use of live fire during last year's deadly crackdown on Gen Z protests - one of the worst in the country's history. And the robot that conducted Denmark's National Symphony Orchestra. We have the verdict on its performance. The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk

We hear from a Mexican city in Sinaloa state where one of the big drug cartels is locked in its own civil war. Our correspondent Quentin Sommerville visited the state capital, Culiacán, where he witnessed scenes of brutal violence that have brought pain and terror to residents. Also: Cuba says its coastguard has killed four people on board a US-registered speedboat, in an exchange of fire off the Cuban coast. It said those on the boat were Cubans, living in the US, with a history of violent activity - and "terrorist" intentions. The American Secretary of State, Marco Rubio, called the shootout "highly unusual" and said the US would conduct its own investigation into the incident and not rely on the Cuban version of events. A British clinical trial on more than 500 people across 15 countries found that a new tablet to treat HIV - which combines two current treatments - is highly effective at keeping the virus suppressed. A BBC Eye investigation has revealed that Nepal's top police officer gave the order allowing the use of live fire during last year's deadly crackdown on Gen Z protests - one of the worst in the country's history. And the robot that conducted Denmark's National Symphony Orchestra. We have the verdict on its performance. The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk

“Being gay is like turning on the sink and water just comes out.” According to a a popular influencer is that Sex is easily obtainable...is it? We discuss... Or is that something only some gay men experience? And if it is easy… why does love feel so much harder? The hosts discuss when they felt like sex was more accessible in gay spaces... Is sex built into our gay community for some of us but then is affection and love that much harder to find without any examples or tools? Do body image, age, race and proximity all affect how gay men obtain sex on the apps? Is sex easier to get in certain spaces... Hot Topic: Disability activist says BBC cut Homophobic slur but kept a racist one in... Hot Topic: Can PrEP among gay Black men be improved when the stats show this community has the highest HIV new infections? Hot Topic: Married influencers Toby and Mikey Perryman-Payne recount be drugged at a gay bar in LA back in 2024 and how it affected them... Hot Topic: Gay Days in Orlando is back! Hot Topic: Gay True Crime Must See TV - "Murder in Glitterball City". Advice: Is it important to date multiple people to decide if the one you are currently dating is the one? Advice: Glory Hole etiquette - is there any etiquette?? Thirst Trap: Which of these 13 models took the best pic of the week? Visit: Steve V's new app - Studio.com/stevev for the website version and visit the app version: Studio.com/stevev/connect Follow Stevie on IG: @iam_stevev Follow Kodi on IG: @mistahmaurice Rate and Review us! Wanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.com Needs some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contact Follow Of a Certain Age on IG: @ofacertainagepod Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It started with a simple moment. Lunch. A new romantic relationship. Feeling good about the future. Then a thought slipped in: what if I have an STD and just don't know it? That's how OCD entered Will Schultz's life. What began as one intrusive question quickly spiraled into fears of HIV, contaminated needles, rabies, and eventually a deep distrust of his own memory and senses.On this episode of the Get to Know OCD podcast, Will shares how that single “what if” thought grew into years of fear, and what finally changed. Even after learning it was OCD and knowing the right treatment, he still struggled to face it. Recovery didn't begin with more reassurance. It began when he made a decision: staying safe was no longer the priority — confronting OCD was.At NOCD, we specialize in exposure and response prevention therapy (ERP), the most effective treatment for OCD—a treatment that can help you live a fulfilling life. If you're ready to take your first step, book a free 15-minute call with us at https://learn.nocd.com/YTFollow us on social media:https://www.instagram.com/treatmyocd/https://twitter.com/treatmyocdhttps://www.tiktok.com/@treatmyocd Hosted on Acast. See acast.com/privacy for more information.

Africa Melane chats to SANAC’s Nelson Dlamini about treasury allocating R26bn to provinces to sustain HIV/AIDS treatment. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

  We welcome Oni Blackstock, M.D., M.H.S., to our miniseries of interviews with people who are leading some of the big conversations we're having as a health care community during a time of great change, and great strain, in HIV care provision within the U.S. Dr. Blackstock shares what has motivated her multiple evolutions along the arc of her career from HIV/PCP physician to NYC DOH assistant commissioner to health equity consultant, and the lessons she has learned along the way.   Read the transcript on TheBodyPro (every click helps!): https://www.thebodypro.com/podcast/hiv/future-hiv-care-oni-blackstock-feb-2026    The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema. Special thanks this month to contributing science editor Roger Pebody for his help with background research and interview prep.

Jase and Al welcome John and Paula Godwin to reflect on the kind of community that shows up in the hardest moments from medical crises to marital collapse and everything in between. They revisit seasons of fear, loss, and uncertainty, including Paula's HIV needle-stick scare and the painful surgeries that tested Jase and Missy's resolve. The conversation builds to the powerful “even if” faith of Daniel 3 — trusting God not only when He delivers what we ask for, but even if He doesn't. In this episode: 1 John 2, verses 3–6; 1 John 3, verses 16–24; 1 John 4, verse 10; Daniel 3, verses 16–18; John 17 “Unashamed” Episode 1277 is sponsored by: https://fastgrowingtrees.com — Get 20% your first purchase when using the code UNASHAMED at checkout. https://bravebooks.com/unashamed — Get 20% off with code UNASHAMED https://myphdweightloss.com — Find out how Al lost 80+ pounds. Schedule your one-on-one consultation today by visiting the website or calling 864-644-1900 and mention "AL" https://ruffgreens.com — Get a FREE Jumpstart Trial Bag for your dog today when you use promo code Unashamed! http://unashamedforhillsdale.com/ — Sign up now for free, and join the Unashamed hosts every Friday for Unashamed Academy Powered by Hillsdale College Check out At Home with Phil Robertson, nearly 800 episodes of Phil's unfiltered wisdom, humor, and biblical truth, available for free for the first time! Get it on Apple, Spotify, Amazon, and anywhere you listen to podcasts! https://podcasts.apple.com/us/podcast/at-home-with-phil-robertson/id1835224621 Listen to Not Yet Now with Zach Dasher on Apple, Spotify, iHeart, or anywhere you get podcasts. Chapters: 00:00 Welcome John & Paula Godwin 04:20 Mia's Surgery & Showing Up in Crisis 09:40 Paula's First Impression  16:15 Marriage Collapse & Carrying Grace 24:30 Becoming Grandparents After Loss 30:50 Why Real Community Requires Commitment 37:40 Believe in Jesus & Love One Another 44:45 The “Even If” Faith of Daniel 3 52:30 Godwin's Fishing Guide Life -- Learn more about your ad choices. Visit megaphone.fm/adchoices

The United States is ending its health programmes in Zimbabwe, including HIV treatment for one point two million people. The US embassy said Harare had pulled out of negotiations over a new health aid agreement which would have provided 367 million dollars over five years. The US has been renegotiating aid to Africa following the abolition of USAID by President Trump.   Also on the programme: The influential economist, Larry Summers, resigns from Harvard over the Epstein files and the Microsoft co-founder, Bill Gates, apologises to staff about his links with the convicted sex offender; and we'll hear why Emperor penguins are facing the threat of extinction.   (Photo shows a health official opening a rapid HIV test during the launch of Lenacapavir, a long‑acting HIV prevention injection outside Harare, Zimbabwe on 19 February 2026.Credit: Philimon Bulawayo/Reuters)

This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.

Robin Beach is an HIV specialist who began to turn a critical eye to the usefulness of body mass index (BMI) when it came to understanding the overall health of a patient. On the latest episode of NP Pulse: The Voice of the Nurse Practitioner®, she speaks with Sophia Thomas about using waist circumference as a way to measure the health of specific patient populations instead of BMI, and offers practical strategies for bringing this new tool into routine practice. 

Drugs and gangs have created an explosion in HIV cases in Fiji.This week on Battle Lines: Global Health Security, Arthur Scott-Geddes is joined by Sarah Newey, The Telegraph's correspondent in Bangkok who recently travelled to Fiji, and Dr Jason Mitchell, the head of the country's HIV task force.On the archipelago known as the gateway to the Pacific, Chinese triads, Mexican cartels, and Australian biker gangs are all involved in a booming methamphetamine trade.The result is that an island paradise is now home to the fastest-growing HIV epidemic on earth.Read Sarah's dispatch from Fiji:The island paradise with the world's fastest growing HIV epidemichttps://www.telegraph.co.uk/global-health/science-and-disease/fiji-island-paradise-with-the-worlds-fastest-growing-HIV-epidemic/Producer: Sophie O'SullivanExecutive Producer: Louisa WellsStudio Operator: Meghan Searle► Sign up to our most popular newsletter, From the Editor. Look forward to receiving free-thinking comment and the day's biggest stories, every morning. telegraph.co.uk/fromtheeditorContact us with feedback or ideas:battlelines@telegraph.co.uk@venetiarainey@ascottgeddes Hosted on Acast. See acast.com/privacy for more information.

In episode 69 of Going anti-Viral, Dr Kevin Saunders joins host Dr Michael Saag to discuss a plenary presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences' Most Difficult Vaccines. Dr Saunders is the associate director for the Duke Human Vaccine Institute and the Norman L. Letvin Professor in Immunology and Infectious Diseases Research. Dr Saunders leads a translational research program that designs and evaluates HIV-1 vaccines. Dr Saunders shares his journey from studying T-cell immunity to pioneering HIV vaccine research. He discusses the challenges of developing an HIV vaccine, the promise of broad neutralizing antibodies, and the innovative use of mRNA technology. Dr Saunders also shares his outlook and optimism for the next 5 years of HIV vaccine development including the use machine learning and artificial intelligence technologies to accelerate the development timeline.0:00 – Introduction 1:36 – Path to HIV research and vaccine development3:50 – Understanding T-cell immunity and HIV6:53 – Transition to passive immunity and broad neutralizing antibodies11:35 – Challenges in developing an HIV vaccine15:25 – Current state of HIV vaccine research17:38 – The role of immunogens in vaccine development20:30 – Combining B-cell and T-cell responses24:59 – Prospect for a HIV vaccine within the next 5 yearsResources:CROI 2026: https://www.croiconference.org/Duke Human Vaccine Institute - https://dhvi.duke.edu/__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Particulate matter is, Michael Greenstone argues, the greatest public health threat on the planet. Worse than HIV, cigarettes, and alcohol. The average person  loses about two years of life expectancy to it. In India, the figure is three and a half years. The solution to this problem has been tested, and it works, at least in high-income countries.Greenstone and his co-authors ran a randomised controlled trial in Surat, Gujarat: from 300 industrial plants, mostly making textiles, all burning coal, half were randomly assigned to a market where pollution permits could be bought and sold. The results: in the market, pollution fell 25%, compliance was near-perfect, and abatement costs dropped 12%. The cost-benefit ratio is as high as 200 to one. Many plants in the control group asked to be moved into the market.The research behind this episode:Greenstone, Michael, Rohini Pande, Nicholas Ryan, and Anant Sudarshan. 2025. "Can Pollution Markets Work in Developing Countries? Experimental Evidence from India." Quarterly Journal of Economics 140 (2): 1003–1060. An ungated version is available as BFI Working Paper 2025-53.To cite this episode:Phillips, Tim. 2025. "Can Pollution Markets Work in Developing Countries?" VoxDev Talk (podcast).  Assign this as extra listening: the citation above is formatted and ready for a reading list or VLE.About Michael GreenstoneMichael Greenstone is the Milton Friedman Distinguished Service Professor in Economics at the University of Chicago, where he is the founding Director of the Energy Policy Institute at Chicago (EPIC) and the Institute for Climate and Sustainable Growth. His research focuses on the costs and benefits of environmental quality, including the Air Quality Life Index, which tracks the toll of particulate pollution country by country. He previously served as Chief Economist for the President's Council of Economic Advisers under President Obama. Research cited in this episodeAir Quality Life Index (AQLI), Energy Policy Institute at Chicago. The source of the life-expectancy statistics used in this episode: particulate pollution costs the average person on Earth roughly two years of life expectancy, with India averaging three and a half years. The index tracks this burden country by country, city by city.The US sulphur dioxide cap-and-trade programme, established under the 1990 Clean Air Act Amendments, was the canonical precedent Greenstone cited: a market that dramatically reduced acid rain in the eastern United States at costs far below pre-programme projections. He noted that the UK and EU have since built comparable CO2 markets. All have worked well. The question this experiment addressed was whether the same logic held in the developing world, where almost all the pollution now is.Emissions Market Accelerator. An independent scale-up organisation founded by Greenstone and colleagues to replicate the Gujarat model beyond the original research setting. Current pipeline: a statewide sulphur dioxide market for Maharashtra (including large power plants, not just textiles), and advanced conversations in Pakistan and Brazil. Within Gujarat, a water pollution market is also in development.More VoxDev Talks on this topicRegulating pollution in low- and middle-income countries Rohini Pande and Nicholas Ryan, two co-authors of the paper discussed in this episode, on the political economy of pollution regulation in developing countries: why enforcement is hard, and what makes it work.Air pollution and infant mortality Jennifer Burney on the health costs of particulate air pollution for young children, and what the evidence from Saharan dust patterns across Sub-Saharan Africa reveals about exposure and mortality.The Social Cost of Carbon Michael Greenstone's earlier VoxDev Talk, on how assigning a monetary value to carbon emissions can drive better policy decisions and make the case for action that regulation alone struggles to make.Related reading on VoxDevReducing air pollution: Evidence from payments to reduce crop burning in India How cash payments to farmers in northern India changed behaviour and cut the seasonal haze from crop fires that pushes Delhi's air quality to its worst each winter.Paying to pollute: How carbon offsets actually raised emissions in China A cautionary study on market-based pollution controls: when incentives point the wrong way, a market can make things worse rather than better.The effect of pollution on worker productivity: Evidence from call-centre workers in China Air pollution reduces cognitive performance and output, adding an economic productivity argument to the health case for cleaning the air.

Against a backdrop of violent anti-semitic and anti-indigenous attacks and the relaxation of police restraints in response to them, Sydney Gay and Lesbian Mardi Gras organizers are faced with twin controversies: the withdrawal of the Jewish group Dayenu from the event and demands for the expulsion of the New South Wales Police contingent. Veteran activist Ken Davis explains the situation (Barry McKay reports). New Yorkers defy the Trump administration and replace the rainbow flag the government “disappeared” from the Stonewall National Monument (Paul DeRienzo of WBAI reports). A Black History Month Rainbow Rewind honors Langston Hughes (produced by Sheri Lunn and Brian DeShazor). And in NewWrap: the European Parliament approves a resolution specifically calling for “the full recognition of trans women as women,” HIV-positive enlistees are once again banned from serving in the U.S. military, intersex children are now protected from undergoing unnecessary medical procedures without their informed consent in the Australian state of Victoria, Kansans can now sue if they're upset after sharing a bathroom with a trans person, U.S. Olympic women's ice hockey team captain Hilary Knight leads her team to gold and plans to lead speed skater Brittany Bowe to the altar, and more international LGBTQ news reported this week by Nico Raquel and Ret (produced by Brian DeShazor). All this on the February 23, 2026 edition of This Way Out! Join our family of listener-donors today at thiswayout.org/donate/.

Infection control consultant Katherine West breaks down the latest HIV post-exposure prophylaxis (PEP) guidelines published in mid-2025. Highlighting key changes since the 2013 update, she explains the shift toward less toxic antiretroviral regimens, elimination of routine baseline lab testing for PEP, and new protocols for exposures involving patients with undetectable viral loads. West emphasizes the importance of expert follow-up care, clarifies who is responsible for source patient testing, and underscores the low risk of occupational HIV transmission. She also discusses challenges faced by emergency providers managing exposures outside regular occupational health hours and the role of 24/7 consultation services. The segment covers legal nuances, especially OSHA and state laws regarding HIV testing consent, and reiterates the CDC's push for routine HIV screening to aid in the national goal of ending the HIV epidemic by 2030.

Další lék proti viru HIV má českou stopu. Zásadní podíl na něm má Tomáš Cihlář se svým kalifornským týmem. Na rozdíl od denně užívaných antivirotik lék stačí injekčně aplikovat dvakrát ročně a funguje i jako prevence. „Myslím, že naše látka může významně přispět k omezení počtu nových infekcí,“ říká v Leonardu Plus Tomáš Cihlář, viceprezident pro virologii společnosti Gilead Sciences, kterého časopis Time zařadil mezi sto nejvlivnějších lidí světa.

Další lék proti viru HIV má českou stopu. Zásadní podíl na něm má Tomáš Cihlář se svým kalifornským týmem. Na rozdíl od denně užívaných antivirotik lék stačí injekčně aplikovat dvakrát ročně a funguje i jako prevence. „Myslím, že naše látka může významně přispět k omezení počtu nových infekcí,“ říká v Leonardu Plus Tomáš Cihlář, viceprezident pro virologii společnosti Gilead Sciences, kterého časopis Time zařadil mezi sto nejvlivnějších lidí světa.Všechny díly podcastu Leonardo Plus můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

──────────────────────────────────────── 00:00:42:27 — Cybersecurity as Power, Not ProtectionCybersecurity is framed as a tool for centralized control and regime continuity rather than public safety, with Palantir cited as emblematic of surveillance-state architecture. ──────────────────────────────────────── 00:02:06:22 — Pam Bondi's Epstein Record ReexaminedQuestions resurface about Bondi's inaction on Epstein cases despite a public reputation for aggressively prosecuting trafficking crimes. ──────────────────────────────────────── 00:08:38:07 — Trump–Epstein Social Ties RevisitedPrior associations and evasive statements are revisited amid renewed scrutiny of elite political networks. ──────────────────────────────────────── 00:16:02:29 — From Ministry to Cold-Turkey Heroin RecoveryA missionary outreach in 1980s Madrid evolves into an international addiction recovery model emphasizing discipline, structure, and community over substitution therapy. ──────────────────────────────────────── 00:29:23:23 — Heroin, Shared Needles, and Spain's AIDS ExplosionIntravenous drug culture and prison conditions accelerate HIV transmission during one of Europe's worst heroin crises. ──────────────────────────────────────── 00:31:56:02 — Addiction as Spiritual and Social BreakdownRecovery is framed as rooted in restored relationships, accountability, and moral transformation rather than purely medical intervention. ──────────────────────────────────────── 00:58:25:07 — Palantir Hack and the “Backdoor State”Alleged breaches raise fears of embedded surveillance backdoors across government and corporate systems. ──────────────────────────────────────── 01:07:07:00 — Internet of Things as National Security LiabilityExpanding military and infrastructure interconnectivity is portrayed as multiplying systemic vulnerabilities rather than strengthening defense. ──────────────────────────────────────── 01:12:03:04 — Pentagon AI Expansion Despite Repeated BreachesVault 7, NSA hacks, and other incidents are cited as evidence that automation and AI integration are outpacing competence and safeguards. ──────────────────────────────────────── 01:17:22:01 — Offline Nuclear Systems vs. Cloud DefenseCold War air-gapped missile systems are contrasted with today's cloud-dependent defense architecture. ──────────────────────────────────────── 01:36:10:00 — Low-Tech Tools Defeat High-Tech DronesSimple heat shielding and optical tricks demonstrate asymmetric weaknesses in advanced surveillance and warfare technology. ──────────────────────────────────────── 01:44:29:12 — Autonomous Vehicle Ethics and Control HierarchiesAI-driven transportation raises unresolved questions about programmed value judgments, liability, and loss of human override authority. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

In his new book Shooting Up: A Memoir of Love, Loss and Addiction, Jonathan Tepper recounts growing up in Madrid's heroin epidemic as his missionary parents built a grassroots rehab network in one of Europe's hardest-hit neighborhoods. Surrounded by addicts, crime, and a generation devastated by HIV, he watched lives restored through faith and discipline—while also burying friends and even his own brother after a tragic accident. This is a stark, deeply personal account of addiction, redemption, and what sacrificial love looks like in the middle of cultural collapse. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

──────────────────────────────────────── 00:00:42:27 — Cybersecurity as Power, Not ProtectionCybersecurity is framed as a tool for centralized control and regime continuity rather than public safety, with Palantir cited as emblematic of surveillance-state architecture. ──────────────────────────────────────── 00:02:06:22 — Pam Bondi's Epstein Record ReexaminedQuestions resurface about Bondi's inaction on Epstein cases despite a public reputation for aggressively prosecuting trafficking crimes. ──────────────────────────────────────── 00:08:38:07 — Trump–Epstein Social Ties RevisitedPrior associations and evasive statements are revisited amid renewed scrutiny of elite political networks. ──────────────────────────────────────── 00:16:02:29 — From Ministry to Cold-Turkey Heroin RecoveryA missionary outreach in 1980s Madrid evolves into an international addiction recovery model emphasizing discipline, structure, and community over substitution therapy. ──────────────────────────────────────── 00:29:23:23 — Heroin, Shared Needles, and Spain's AIDS ExplosionIntravenous drug culture and prison conditions accelerate HIV transmission during one of Europe's worst heroin crises. ──────────────────────────────────────── 00:31:56:02 — Addiction as Spiritual and Social BreakdownRecovery is framed as rooted in restored relationships, accountability, and moral transformation rather than purely medical intervention. ──────────────────────────────────────── 00:58:25:07 — Palantir Hack and the “Backdoor State”Alleged breaches raise fears of embedded surveillance backdoors across government and corporate systems. ──────────────────────────────────────── 01:07:07:00 — Internet of Things as National Security LiabilityExpanding military and infrastructure interconnectivity is portrayed as multiplying systemic vulnerabilities rather than strengthening defense. ──────────────────────────────────────── 01:12:03:04 — Pentagon AI Expansion Despite Repeated BreachesVault 7, NSA hacks, and other incidents are cited as evidence that automation and AI integration are outpacing competence and safeguards. ──────────────────────────────────────── 01:17:22:01 — Offline Nuclear Systems vs. Cloud DefenseCold War air-gapped missile systems are contrasted with today's cloud-dependent defense architecture. ──────────────────────────────────────── 01:36:10:00 — Low-Tech Tools Defeat High-Tech DronesSimple heat shielding and optical tricks demonstrate asymmetric weaknesses in advanced surveillance and warfare technology. ──────────────────────────────────────── 01:44:29:12 — Autonomous Vehicle Ethics and Control HierarchiesAI-driven transportation raises unresolved questions about programmed value judgments, liability, and loss of human override authority. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

In his new book Shooting Up: A Memoir of Love, Loss and Addiction, Jonathan Tepper recounts growing up in Madrid's heroin epidemic as his missionary parents built a grassroots rehab network in one of Europe's hardest-hit neighborhoods. Surrounded by addicts, crime, and a generation devastated by HIV, he watched lives restored through faith and discipline—while also burying friends and even his own brother after a tragic accident. This is a stark, deeply personal account of addiction, redemption, and what sacrificial love looks like in the middle of cultural collapse. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

"Because the premise of immune checkpoint blockade centers around elevating the immune function, we should always take a great deal of caution around those patients who have high immune risks. Those include patients with autoimmune disorders. That's one of our biggest questions that we ask, usually every consult that we're seeing with solid tumor. 'Do you have any history of autoimmune disorders? Tell me a little bit more about it. Is it being treated? What are your symptoms like?' And then also patients who have undergone organ transplants. Now, interestingly, this does include stem cell transplants," Kelsey Finch, PharmD, BCOP, oncology pharmacist practitioner at Columbus Regional Health in Indiana, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about checkpoint inhibitors. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 20, 2027. Kelsey Finch has disclosed a speakers bureau relationship with AstraZeneca. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to checkpoint inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 273: Updates in Chemotherapy and Immunotherapy Episode 174: Administer Pembrolizumab Immunotherapy With Confidence Episode 139: How CAR and Other T Cells Are Revolutionizing Cancer Treatment ONS Voice articles: Here's Why Oncology Nurses Are Pivotal in Managing Immune-Related Adverse Events Make Subcutaneous Administration More Comfortable for Your Patients Nursing Considerations for ICI-Related Myocarditis Oncology Nurses Navigate the Changing Landscape of Immuno-Oncology Postdischarge ICI Patient Education Eliminates Hospital Readmissions Shorter Administration Times Still Require High-Acuity Care ONS Voice oncology drug reference sheets: Dostarlimab-Gxly Nivolumab and Hyaluronidase-Nvhy Nivolumab and Relatlimab-Rmbw Pembrolizumab and Berahyaluronidase Alfa-Pmph Retifanlimab-Dlwr Toripalimab-Tpzi ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Guide to Cancer Immunotherapy (second edition) ONS course: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ Clinical Journal of Oncology Nursing articles: Immune Checkpoint Inhibitor–Related Myocarditis: Recognition, Surveillance, and Management Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers ONS Huddle Cards: Checkpoint Inhibitors Immunotherapy ONS Learning Libraries: Genomics and Precision Oncology Learning Library Immuno-Oncology Learning Library Drugs@FDA package inserts National Comprehensive Cancer Network homepage OncoLink: All About Immunotherapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Before immune checkpoint blockade, the two-year overall survival rate in metastatic melanoma was hovering around 10%. After these agents came to market, depending on the trial and the agents used, that number actually increased to about 50%–65%. So, five times the amount of patients were actually living at the two-year mark. Not surprisingly, studies then exploded across several tumor types, leading to approvals in all sorts of cancers, mostly in the solid tumor. But there are a couple hematologic as well. Lung cancer, kidney cancer, head and neck, Hodgkin lymphoma, hepatocellular, the list goes on. So, it's really just transforming the stage IV setting across all tumors, specifically from uniformly fatal prognosis to one where durable responses and long-term survival is also possible." TS 3:03 "There are four different mechanisms officially being used in therapies that are approved by the U.S. Food and Drug Administration (FDA). Those are cytotoxic T-lymphocyte–associated protein 4, programmed cell death protein 1, and programmed cell death ligand 1, which I'm counting as two different mechanisms, even though they somewhat work together. And lymphocyte-activation gene 3 is the fourth one that's in there. So, all these mechanisms impact the T cell in our immune system. The T cell is traditionally responsible for protecting our body from harmful things like bacteria, viruses, and cancer. When the tumor binds to cytotoxic T-lymphocyte–associated protein 4 receptors, that happens on the T cell itself. And that inhibits the activation of the T cells, essentially allowing that tumor to then live. So when developing medications that block this receptor, they noted an added benefit that it actually increased the T-cell proliferation as well as keeping that T cell active. So not only are we not blocking the T cells, we're making them more productive." TS 5:38  "If you have a chance of any sort of tissue rejection, specifically with allogeneic stem cell transplants or where we see that focusing on it, there's a little bit of controversy, mixed bag on opinions as far as autologous stem cell transplants. But it's best to at least exercise a little bit of caution. If they have a chance of organ rejection, is that worth the risk of the therapy that we're looking to give? And then, patients with HIV, any sort of immunologic concerns at baseline that we could potentially worsen." TS 14:37 "As a rule of thumb, with immune checkpoint blockade, regardless of what mechanism you're looking at, if something in your body can get inflamed, that can wind up as an adverse event. So, whenever I talk to my patients, the key word is anything ending in '-itis.' ... The most common adverse events that we end up seeing are dermatitis and hypothyroidism. Immune checkpoint blockade can cause both hyper- and hypothyroidism. Very often, we actually start in the hyper- and then end up, for lack of better words, burning out the thyroid, ultimately leading to a sustained hypothyroidism." TS 18:34 "The half-life of immune checkpoint inhibitors is usually around 30 days, meaning that once these agents are given, the drug will be in the patient's system for up to five months. Specifically, it will probably build month to month, so often we don't even see a lot of our adverse events until month three or four. Usually, when we're that far into treatment, we're not looking for new adverse events in things like chemotherapy. But these drugs do build over time." TS 24:28 "As far as safe handling is concerned, these agents are not chemotherapy. That makes drug compounding and administration pretty straightforward. When looking at the follow-up care, the most important thing, in my opinion, is to engage in meaningful dialogue with your patients. A lot of the side effects can be nonspecific. So, really listening to the patient and evaluating changes in their lifestyle, I think it'll get you far. We usually hark in on the new, worsening, or persistent whenever we're talking to patients because they'll be looking for things as well. So, just having a dialogue of how their life has changed can certainly help." TS 26:17

Tanya was diagnosed with HIV when she was 21 years old, at a time when it was viewed as a death sentence. She began speaking at this time about resilience, sharing her story with medical professionals and more. As a speaker decades later, Tanya brings the same insight, empathy and authenticity to live audiences, guiding professional women and entrepreneurs to embrace visibility, clarity and confidence. Tanya hopes people will stop waiting for “someday” and remember that TODAY is always the best day to take small steps toward big, bold moves.Tanya Boggs is a personal brand photographer, visual strategist, storyteller and speaker who helps women step boldly into their next chapter — whether in business, life transitions or leadership. She creates imagery and experiences that don't just capture a moment; they reflect identity, ambition and the truth of who her clients are becoming.For women seeking an intentional, high-impact refresh, Signature Shot Sessions offers a focused, transformative portrait session designed to elevate visibility and clarify presence. For leaders and entrepreneurs whose brands evolve constantly, Signature Shot Creative provides a year-long, residency-style partnership with quarterly sessions, ongoing visual strategy and seasonal content that ensures their visuals always match their momentum. Her You Are Here Portrait Experience is a deeply transformational space for women reclaiming their narrative, honoring their past and stepping fully into the life and brand they are creating.Tanya is also the host of the You Are Here Podcast, sharing conversations with women who have navigated reinvention, resilience and transformation — amplifying stories that inspire listeners to show up boldly and intentionally. She especially highlights stories of overcoming trauma and difficulties. I was honored to be a guest on Tanya's podcast!Being bi-coastal between Charleston and Southern California, Tanya blends refined artistry with strategic heart. Her work is for women who are done hiding, done playing small and ready to be unmistakable — in business, in leadership and in life.Learn more and follow Tanya: tanyaboggs.comInstagram: ⁠https://www.instagram.com/tanyaboggsphoto⁠⁠https://www.instagram.com/theyouareherepodcast⁠Facebook: ⁠https://www.facebook.com/TheYouAreHerePodcast⁠⁠https://www.facebook.com/TanyaBoggs.Photographer⁠⁠https://www.facebook.com/tanya.boggs⁠LinkedIn: ⁠https://www.linkedin.com/in/tanyaboggsphotographer/⁠Podcast List: ⁠https://open.spotify.com/show/6eGfSl7zjcBJMpGD7N6KXb⁠⁠https://podcasts.apple.com/us/podcast/you-are-here-a-grateful-twist-on-lifes-disruptions/id1804677562⁠⁠https://www.youtube.com/@You_Are_Here_Podcast⁠⁠https://theyouareherepodcast.substack.com/profile/posts

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation.   Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Pre-exposure prophylaxis for HIV. Previous episodes related to HIV:  -Episode 67, HIV history (September 2021) -Episode 68, HIV transmissibility (October 2021) -Episode 70 (October 2021), HIV prevention (including HIV Prep with oral medications) -Episode 98 (June 2022), we introduced Apretude, the first injectable for HIV PrEP. Apretude was approved in December 2021.  What is Pre-Exposure prophylaxis (PrEP)? Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medications taken by individuals who are HIV-negative to prevent HIV acquisition. There are 30,000 new HIV infections annually in the US.  How effective is it? When taken as prescribed, PrEP is highly effective at reducing the risk of HIV transmission through sexual exposure and injection drug use. Patients who are adherent to PrEP can lower their risk of contracting HIV by 99%. The effectiveness of oral PrEP is highly adherence dependent. In trials with 70% adherence, the relative risk of HIV acquisition was 0.27, compared to 0.51 with 40-70% adherence and no significant benefit with adherence ≤40%. How does PrEP work? PrEP works by maintaining therapeutic drug levels in the bloodstream and in target tissues. If HIV exposure occurs, viral replication is inhibited, preventing the establishment of infection. Brief History of PrEP. The concept of PrEP originated from early animal studies demonstrating that antiretroviral medications could prevent retroviral transmission when administered before exposure. In 2010, the iPrEx trial showed that daily oral tenofovir disoproxil fumarate (known as Truvada) with emtricitabine significantly reduced HIV acquisition among men who have sex with men and transgender women. This was the first large clinical trial to demonstrate the effectiveness of PrEP. In 2012, the FDA approved oral Truvada, which is TDF/FTC (tenofovir disoproxil and emtricitabine) for HIV prevention. Since then, additional studies have expanded indications and introduced new formulations, including long-acting injectable options. Who Should Be Offered PrEP? PrEP should be considered for any HIV-negative individual at increased risk of HIV acquisition, including Men who have sex with men, transgender individuals, heterosexual men and women with an HIV-positive partner, individuals with recent bacterial sexually transmitted infections, people who inject drugs, individuals engaging in condomless sex with partners of unknown HIV status. Remember that PrEP should be offered in a nonjudgmental, patient-centered manner, make it a safe space to talk openly about prevention of HIV.  Available HIV PrEP Options. Daily Oral PrEP: There are 2 formulations of Tenofovir. There is Tenofovir disoproxil fumarate (TDF)/ Truvada and Tenofovir alafenamide (TAF)/ Descovy. Each is available in a tablet combined with Emtricitabine a nucleoside reverse transcriptase inhibitor. Truvada: It is approved for all populations at risk through sexual exposure or injection drug use. Something to look out for before starting this medication is for pre-existing CKD. Do not give to patients who have an estimated glomerular filtration rate of less than 60 mL/min. (6) Descovy: This option is approved for men who have sex with men and transgender women but is not approved for individuals at risk through receptive vaginal sex. It has less impact on renal function and bone mineral density compared to Truvada. It can be used in moderately reduced kidney function (GFR between 30-60 mL/min). Truvada and Descovy are taken orally once a day.  After patients start taking these medications, when are they considered to be protected?  Nicole: With daily oral PrEP, guidelines differ with WHO and International Aids Society-USA stating it takes about 7 days, while CDC states 21 days to allow for adequate concentration in tissues (1). Adherence is critical for efficacy. Injectable HIV PrEP. In 2021, the FDA approved the first Injectable PrEP option Long-acting cabotegravir (CAB-LA)- known on the market as Apretude. Cabotegravir is an integrase strand transfer inhibitor administered as an intramuscular injection.Dosing consists of an initial injection, a second injection one month later, and then maintenance injections every two months (1). Another option is Lenacapavir (Yeztugo). The Yeztugo as a pre-exposure prophylaxis (PrEP) for HIV in Oct 2024. Yeztugo is the first and only FDA-approved HIV prevention treatment that requires just two injections per year, offering a long-acting option for people who weigh at least 35kg. It is given as 2 injections every 6 months. First dose is given with 2 tablets on Day 1 and Day 2, then every 6 months 2 injections on the same day. Clinical trials, including HPTN 083 and HPTN 084, demonstrated that injectable cabotegravir is superior to daily oral PrEP in preventing HIV infection. This advantage is largely due to improved adherence rather than differences in intrinsic drug potency. There have been no head-to-head comparisons between Yeztugo and Apretude, but they are both very effective. Apretude starts protecting 7 days after the first dose, and Yeztugo starts protecting 2 hours after Day 2 (if patient takes the oral loading dose) or 3-4 weeks if no oral load is taken. Injectable PrEP is particularly beneficial for patients who struggle with daily pill adherence, have trouble swallowing pills, prefer a discreet option, have difficulty storing their medication or have renal or bone disease that limits the use of tenofovir-based regimens like Truvada and Descovy (6). In one unpublished report by Medline, patients who received Apretude had an increase in bone mineral density compared to those who received Truvada (1). Tests prior to starting PrEP. Before initiating PrEP, patients must be confirmed to be HIV-negative. Baseline evaluation includes HIV testing with a fourth-generation antigen/antibody assay, HIV RNA testing if acute infection is suspected, renal function testing for oral PrEP, Hepatitis B screening, sexually transmitted infection screening, and pregnancy testing when appropriate. PrEP should not be started in individuals with known or suspected acute HIV infection. Monitoring for patients on HIV PrEP. Monitoring typically includes HIV testing every 2 to 3 months, STI screening every 3 to 6 months, renal function monitoring for those on oral PrEP (tenofovir- based), ongoing adherence and risk-reduction counseling. And for injectable PrEP, adherence to the injection schedule is essential, as delayed dosing may increase the risk of resistance if HIV infection occurs. HIV PrEP is not a prevention for other STIs. Screening for STIs and counseling about prevention is essential. Breakthrough HIV infections on PrEP are rare and most often associated with poor adherence or delayed diagnosis. Truvada is more studied in all populations and is considered safe during pregnancy and breastfeeding. There is less data regarding the injectable option in patients who are pregnant, may become pregnant, or whose primary risk factor is injection drug use (1). Injectable PrEP provides an important alternative for patients with chronic kidney disease and bone disease (1). Key Takeaway Pre-exposure prophylaxis is a safe, effective, and evidence-based strategy for HIV prevention. With both daily oral and long-acting injectable options available, PrEP can be individualized to meet patient needs. Normalizing PrEP discussions in clinical practice is essential to reducing new HIV infections and advancing public health goals.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  References: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. The Journal of the American Medical Association. 2025. Gandhi RT, Landovitz RJ, Sax PE, et al. Long-Acting Lenacapavir Acts as an Effective Preexposure Prophylaxis in a Rectal SHIV Challenge Macaque Model. The Journal of Clinical Investigation. 2023. Bekerman E, Yant SR, VanderVeen L, et al. Pharmacokinetics and Safety of Once-Yearly Lenacapavir: A Phase 1, Open-Label Study. Lancet. 2025. Jogiraju V, Pawar P, Yager J, et al.

We explore the FDA's expansion of Wakix as the first non-scheduled treatment for pediatric cataplexy; a Taltz and Zepbound combo shows promise in skin clearance for patients with psoriasis and obesity; we also look at the frontier of mental health with synthetic psilocybin; there's phase 3 results from a potential new treatment for chronic inducible hives; and a long-acting HIV injection could be a game-changer for patients who struggle with the daily pill grind.  

"He lies so much that he lies even when he just says, 'Good morning.'" Pablo's latest episode tells the previously untold story of how a former Miami Heat player and current DJ, Rony Seikaly, changed the perception of HIV forever by playing a single game of one-on-one, but Dan's more concerned with the fact that Pablo seems to be broadcasting to us from a can of some sort. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Tom opens this week's livestream with updates and announcements:He thanks the community for their continued support and invites listeners to help reach 100,000 followers on Facebook. If you haven't already, make sure you follow us on Facebook.Registration remains open for the New Biology Experience at Polyface Farm (June 2026). Tom encourages early sign-up while space is still available and reminds everyone that early bird pricing is still an option.New Biology Experience link here.This week's session centers around a core theme: separating what we actually observe from the stories we construct about what we think is happening.A thoughtful Q&A on:-What about HIV and hep C that people get from blood transfusions?-Does DNA testing detect consciousness in structured water?-How and when to use chlorine dioxide solution?-What about fever in children? When is this bad?-Is there such a thing as terminal or incurable illness?-Can you use food as medicine?-What do I think about biofield tuning?Throughout the session, Tom returns to a central question: “What do you see?” He challenges viewers to distinguish direct experience—what we see, feel, hear, smell, and taste—from the explanations layered on top of it.Support the showWebsites:https://drtomcowan.com/https://www.drcowansgarden.com/https://newbiologyclinic.com/https://newbiologycurriculum.com/Instagram: @TalkinTurkeywithTomFacebook: https://www.facebook.com/DrTomCowan/Bitchute: https://www.bitchute.com/channel/CivTSuEjw6Qp/YouTube: https://www.youtube.com/channel/UCzxdc2o0Q_XZIPwo07XCrNg

In episode 68 of Going anti-Viral, Dr Ruanne Barnabas joins host Dr Michael Saag to discuss topic of a symposium session at the upcoming the Conference on Retroviruses and Opportunistic Infections (CROI) entitled Strategic and Resilient Responses to the Funding Crisis Across Africa. Dr Barnabas is the Chief of the Division of Infectious Diseases at Massachusetts General Hospital. Her work is focused on identifying effective and scalable HIV, HPV, and infectious diseases treatment and prevention strategies that increase access across diverse communities and promote equity in health. Dr Barnabas discusses the substantial progress made in global health, particularly in HIV treatment and prevention. She also discusses the impact of funding cuts from USAID on health systems and highlights with Dr Saag the importance of the US President's Emergency Plan for AIDS Relief (PEPFAR) in delivering effective care. Dr Barnabas outlines the presentations to be given at the upcoming symposium at CROI 2026 addressing the HIV funding crisis, emphasizing community resilience, and the future of health equity.0:00 – Introduction1:29 – Overview of global health funding at the end of 20244:03 – Success of PEPFAR and USAID10:25 – Funding cuts and their consequences12:48 – Overview of the CROI 2026 symposium on the HIV funding crisis in Africa16:28 – Community perspectives and impact of new technologies18:08 – Lessons learned from funding cuts21:13 – Looking ahead: future of HIV and global health programsResources:CROI 2026: https://www.croiconference.org/Going-anti-Viral: Episode 43 - Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind - Dr Izukanji Sikazwe__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

This week, we're revisiting an episode where Marianna sat down with John Faragon to talk about post-exposure prophylaxis in pocket or PIP. Listen in to learn all about what it is, who it's for, and how it can help prevent HIV for more people.-- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Welcome to The Daily Wrap Up, an in-depth investigatory show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (2/18/26). As always, take the information discussed in the video below and research it for yourself, and come to your own conclusions. Anyone telling you what the truth is, or claiming they have the answer, is likely leading you astray, for one reason or another. Stay Vigilant. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble");   Rumble("play", {"video":"v73rjxu","div":"rumble_v73rjxu"}); Video Source Links (In Chronological Order): The Empire Above Epstein & The Tightening Grip Of Its Enforcement Arm (10) The Last American Vagabond on X: "This should have been at the end of my show today. Would have perfectly tied it together: https://t.co/dit2hgoxGk "The Empire Above Epstein & The Tightening Grip Of Its Enforcement Arm"" / X The Empire Above Epstein (10) Jay Anderson on X: ""They have figured out their world is an illusion, their perception is engineered, their leaders are puppets, their entertainment is a distraction, their labour is meaningless, but will they do anything about it?" https://t.co/IaCjKPnxAK" / X New Tab (10) Jeff Carlson on X: "We have a government. But it's not ours." / X (10) Shadow of Ezra on X: "Tucker Carlson said he and his staff were detained in Israel following an interview with Mike Huckabee. Israeli officials confiscated his passport and took his executive producer to an interrogation room. The officials demanded to know what they spoke to Mike Huckabee about. https://t.co/HDV1jNAynz" / X (10) Dominic Michael Tripi on X: "NEW: Trump told Tucker Carlson to “turn down the temperature” on GOP rift over Israel, Carlson now currently visiting Israel, per the Jerusalem Post." / X Donald Trump behind Tucker Carlson's Israel visit to make amends | The Jerusalem Post (12) DD Geopolitics on X: "The USA is so fucking depraved the President's son is taking an ISRAELI company public that advertises 'low cost-per kill.' You do not hate these people enough. https://t.co/vGO4a9UDS0" / X Backed by Trump's son, Israeli-founded AI drone startup plans to go public on Nasdaq | The Times of Israel Charlie Kirk refused Netanyahu funding offer, was ‘frightened' by pro-Israel forces before death, friend reveals - The Grayzone Trump received morbid gift from Israel's Prime Minister during White House visit | The Independent Israel accused of planting mysterious spy devices near the White House - POLITICO (12) Ron Paul on X: "Why is a U.S. Senator from South Carolina going to Israel "every 2 weeks"? Lindsey Graham said in a speech (from Israel) that if Iran ends up hitting U.S. troops in the region ... it's worth the risk of attempting regime change. https://t.co/ufr8lwWUFR" / X New Tab Les Wexner's Very Bad Week: Billionaire Forced to Testify About Epstein and OSU Sexual Abuse Scandal (12) The Last American Vagabond on X: "Rep Dave Min claims not a single Republican showed up for the deposition of Les Wexner to today. https://t.co/55uAj4YomT" / X (14) The Last American Vagabond on X: "Maybe Jordan is trying to draw attention away from his involvement with the Les Wexner deposition today: https://t.co/86EHhRZxyj" / X New Tab (14) Art Vandelay on X: "Nancy follows me, so maybe she'll see this... I am asking politely for our elected officials to stop this madness. It's over. MAGA influencers lied to their audience for years about this crap. And then, MAGA friendly politicians like Nancy Mace, took the cheese, just like" / X (14) Harrison H. Smith ✞ on X: "Here's the weird thing about this... Trump is not in the Epstein files like they are insinuating. There are a bunch of ridiculous and disproved "allegations," but nothing of substance. HOWEVER, people close to Trump like Howard Lutnick ARE implicated throughout the files. So" / X (14) Clayton Morris on X: "This is actually real. I had to read it twice. So you're saying @RepThomasMassie calling for the release of the Epstein Files is preventing the DOJ from going after criminals? Meaning there are no criminals in the Epstein Files? Murderers, cannibals, sex traffickers, child" / X New Tab (18) Jeff Carlson on X: "Remember when the DOJ and FBI tried to convince us there was no client list, no persons of interest, told us Epstein killed himself and tried to pronounce the entire Epstein Case closed? None of these people & institutions are worthy of our trust." / X (14) John Achterhof on X: "@krystalball https://t.co/52NxGHdSYG" / X (14) Brian Allen on X: "

Breakthrough treatments for high blood pressure, HIV infection and obesity: they're all available in part because of studies done on animals. And though the Animal Welfare Act has for many years regulated the treatment of lab animals, more than 95% of those used in research today are excluded from its protections. Larry Carbone is a veterinarian who's spent decades caring for animals in research facilities. We talk to him about the value and ethics of animal research and what he thinks needs to change. His new book is “The Hidden Lives of Lab Animals.” Guests: Larry Carbone, laboratory veterinarian; author, "The Hidden Lives of Lab Animals: A Vet's Vision for a More Humane Future" Learn more about your ad choices. Visit megaphone.fm/adchoices

Many people mistakenly believe that the AIDS and HIV crises are over. Nothing is further from the truth. AIDS Foundation Chicago continues to provide care and housing assistance for so many Chicagoans who may struggle to make ends meet while they continue their battle against HIV. It is true that medications are better and more […]

Early last year, a hundred researchers, clinicians and other experts on HIV discussed the development of an innovative vaccine that could prevent the disease. But just as the meeting was about to wrap up, the mood darkened. A new executive order signed by President Trump on Inauguration day had frozen all foreign aid, pending a review. Soon, DOGE would begin its decimation of USAID — and with it, this vaccine trial. That is – until the South African researchers came up with a new plan. Read more of freelance science reporter Ari Daniel's story here.Interested in more on the future of science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this President's Day Radar Brief of The Wright Report, Bryan previews major stories unfolding at home and abroad, including troubling new details in the Nancy Guthrie kidnapping case in Tucson and a notable shift as Minnesota Democrats begin cooperating with ICE after weeks of defiance. Bryan also examines Hillary Clinton's surprising admission that open border policies "went too far," outlines President Trump's plan to build 92,000 new detention beds nationwide, and exposes how emotional media narratives often hide critical facts in high-profile immigration cases. He then turns to fresh revelations about partisan lawfare tied to the Trump investigations, new reporting on Jeffrey Epstein and coded communications, and a rare New York Times warning that America's marijuana experiment may be spiraling out of control. The episode closes with unsettling questions about whether advanced AI systems are beginning to think and react like humans, major signals from Europe that 100% solar and wind energy is failing, and encouraging medical breakthroughs in fibromyalgia treatment and immune health research worldwide.   "And you shall know the truth, and the truth shall make you free." - John 8:32     Keywords: February 16 2026 Wright Report, Nancy Guthrie Tucson FBI DNA glove update, Minnesota Democrats cooperate ICE Tim Walz pivot, Hillary Clinton open borders admission Munich, Trump 92000 detention beds plan, Seamus Culleton visa overstay Ireland drug charges, JP Cooney Jack Smith prosecutor runs for Congress, Epstein pizza coded language email dump, New York Times marijuana psychosis warning, AI bot Scott Shambaugh code controversy, Macron Spain blackout solar wind failure, fibromyalgia duloxetine 120 mg study, gut microbiome HIV immune research

I'm joined by Dr. Špela Šalamon, Nuclear Medicine Specialist Physician and biomedical scientist. She has contributed to global efforts in understanding and mitigating the impacts of COVID-19 and published several papers addressing the risks following COVID-19 infections, emphasizing the necessity for proactive health measures. In October of last year, she co-authored and published the AJPM Focus review article, COVID-19 is “Airborne AIDS”: provocative oversimplification, emerging science, or something in between? The review compares and contrasts “observations of the immunological impacts of COVID-19 and HIV infections […] examining shared and distinct mechanisms, such as immune dysfunction, vulnerability to opportunistic infections, accelerated aging and neurocognitive disorders, […] highlight[ing] critical parallels and their implications.” // Episode notes + transcript: https://www.lastborninthewilderness.com/episodes/spela-salamon // Sustain + support: https://www.patreon.com/lastborninthewilderness // Donate: https://www.paypal.me/lastbornpodcast

What happens when humour becomes survival, self expression becomes strength, and healing becomes non negotiable?In this episode of A Life of Greatness, Sarah Grynberg sits down with Jonathan Van Ness, comedian, author, activist, and one of the beloved Fab Five from Queer Eye. From growing up feeling different in the Midwest to finding confidence through comedy, cheerleading, and creativity, Jonathan shares the experiences that shaped their voice, resilience, and sense of purpose.In this episode, you will learn:How humour can become a survival tool and a pathway to connectionWhy early experiences of othering can shape confidence and creativityWhat Queer Eye taught Jonathan about pressure, people pleasing, and boundariesHow therapy and self work have helped navigate fame, criticism, and controversyWhat it really means to live openly with HIV today and why education mattersWhy self acceptance and compassion are essential for lasting joy and healingThis episode is a reminder that greatness is not perfection, but knowing who you are, showing up with honesty, and having faith that we are all going to be okay.Purchase Jonathan's books herePurchase Sarah's book: Living A Life Of Greatness here.To purchase Living A Life of Greatness outside Australia here or here.Watch A Life of Greatness Episodes On Youtube here.Sign up for Sarah's newsletter (Greatness Guide) here.Purchase Sarah's Meditations here.Instagram: @sarahgrynberg Website: https://sarahgrynberg.com/Facebook: facebook.com/sarahgrynbergTwitter: twitter.com/sarahgrynberg Hosted on Acast. See acast.com/privacy for more information.

This week on the Queer News podcast, In top news, The Trump Administration ordered the removal of the pride flag from Stonewall. Cathy Renna was there in person and left us a voicemail to share more about it. In politics, The Trump Administration attempts to revoke $600 million in health care funding from four states who've vocally opposed him, and we break down what the Transgender Bill Of Rights could look like. In culture and entertainment, Don Lemon pleads not guilty to federal charges and the Seeing Her docu-series premieres! Let's get into it.    Want to support this podcast?

Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKenric Ware, Pharm DClinical Associate Professor of Pharmacy PracticeMercer University Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure.2. Describe key considerations for selecting and managing HIV PEP regimens.Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-052-H01-PInitial release date: 2/16/2026Expiration date: 2/16/2027Additional CPE details can be found here.

For HIV Awareness Week, Richie is joined by professionals to discuss the importance of HIV education.Produced by Unedited for BBC Radio 1Xtra.

In this conversation, Jonathan Tepper discusses his memoir 'Shooting Up,' which explores his childhood experiences growing up in a drug rehab center in Madrid, the impact of addiction and HIV on his community, and the personal loss he faced with the tragic death of his brother. Tepper reflects on the lessons learned from these experiences, the importance of empathy, and how they shaped his worldview. He also contrasts his upbringing with the cultural perceptions of addiction and discusses the changes in his neighborhood over the years.00:00 Introduction to Jonathan Tepper and His Memoir02:59 Growing Up in a Drug Rehab Center05:46 The Impact of Addiction and HIV in the Community08:54 Personal Loss and Its Aftermath11:52 Cultural Reflections and Contrasts15:04 The Turning Point: A Tragic Accident18:05 Living One Day at a Time21:11 Reflections on Change and GrowthGuest InformationJonathan TepperWebsite: https://jonathan-tepper.com/Social:YouTube Facebook Instagram TikTokDale AtkinsWebsite: https://www.drdaleatkins.com/Social:YouTube Facebook Instagram TikTokGet your copy of Shooting Up by Jonathan Tepper Get your copy of The Turquoise Butterfly by Dale AtkinsAs an Amazon Associate, Now I've Heard Everything may earn a commission from qualifying purchases.For more intriguing and engaging interviews each week, subscribe now on Spotify, Apple Podcasts. and now on YouTube

Does winter make you crave intimacy more? Does cold weather make sex hotter… or loneliness louder? Do partnered guys feel pressure to perform romance? Do single guys feel invisible? Have you ever scheduled a hookup on Valentine's Day on purpose? Valentine's Day can amplify: Body image insecurity Couple envy “Why am I still single?” Fear of aging alone Hot Topic: Removal of the the Pride flag at the Stonewall Monument by the Trump administration will be restored today at 4PM ET on Thursday February 12, 2026. Hot Topic: Sean Cody Model Eddie Burke as well as others arrested for drug trafficking on a recent gay cruise... Hot Topic: Florida backtracks on HIV funding cuts for now... Hot Topic: From Boyfriend to Betrayal....calling ICE on his boyfriend after 20 years of being together... Hot Topic: One gay content creator tells us his least favorite spots to travel and why and we're celebrating 50 Years of Island House! Advice: Is it too much to bring flowers to someone you've been Facetiming with for your first date? Thirst Trap: Which 13 NSFW performers took the hottest pic of the week? Visit: Feb 5 - Feb. 17 Get 20% Off Steve V's new app - Studio.com/stevev for the website version and visit the app version: Studio.com/stevev/connect Follow Stevie on IG: @iam_stevev Follow Kodi on IG: @mistahmaurice Rate and Review us! Wanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.com Needs some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contact Follow Of a Certain Age on IG: @ofacertainagepod Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

You've got junk, and we have info. The charming and hilarious researcher, professor, sex-positive health advocate, and author of the science book “Strange Bedfellows,” Dr. Ina Park, joins to talk about sores, symptoms, muffs, condoms, testing schedules, titillating vaccine developments, miracle medications, Brazilians, HIV magic, stepping out vs. opening up, toilet seats, antibiotics, new scientific shockers about bacterial vaginosis, crotch crickets, conservative obstructions, the secrets of Columbus, and most importantly how to stay horny, true to yourself, and safe. Whether you're monogamous, open, ace, or dating, she's giving the advice you need to communicate more openly and have more empathy for the health of friends and strangers. Visit Dr. Park's website and follow her on InstagramBuy her book, Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDs, on Bookshop.org or AmazonDonations went to the University of Alabama at Birmingham Dr. C. Kirk Avent Endowed Support Fund and the San Francisco City ClinicMore episode sources and linksOther episodes you may enjoy: Sexology (SEX), Urology (CROTCH PARTS), Phallology (PENISES), Gynecology (NETHER HEALTH), Epidemiology (DISEASES), Biological Anthropology (SEXY APES), Neuroendocrinology (SEX & GENDER), Venusology (VENUS), Carcinology (CRABS), Trichology (HAIR), Eschatology (THE APOCALYPSE)400+ Ologies episodes sorted by topicSmologies (short, classroom-safe) episodesSponsors of OlogiesTranscripts and bleeped episodesBecome a patron of Ologies for as little as a buck a monthOlogiesMerch.com has hats, shirts, hoodies, totes!Follow Ologies on Instagram and BlueskyFollow Alie Ward on Instagram and TikTokEditing by Mercedes Maitland of Maitland Audio Productions and Jake ChaffeeManaging Director: Susan HaleScheduling Producer: Noel DilworthTranscripts by Aveline Malek Website by Kelly R. DwyerTheme song by Nick Thorburn Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

CEREMONIAL SCI OP - 02.09.2026 - #914 BestPodcastintheMetaverse.com Canary Cry News Talk #914 - 02.09.2026 - Recorded Live to 1s and 0s Deconstructing World Events from a Biblical Worldview Declaring Jesus as Lord amidst the Fifth Generation War! CageRattlerCoffee.com SD/TC email Ike for a discount https://CanaryCry.Support   Send address and shirt size updates to canarycrysupplydrop@gmail.com Join the Canary Cry Roundtable This Episode was Produced By:   Executive Producers Michael B*** Sir LX Protocol Baron of the Berrean Protocol***   Producers of TREASURE (CanaryCry.Support) Cage Rattler Coffee   Producers of TIME Timestampers: Jade Bouncerson, Morgan E Clankoniphius Links: JAM   SUPPLY DROP Calendar and Goldback bonus to new sign ups   OLYMPICS DEVIL 2:48 Ring "Search party"  Clip: Olympics Pentagram Clip: Spiral imagery at opening ceremony (X) Clip: Israeli's boo'd at opening ceremony, walking through Stargate (X) Clip: Israel boo'd? (X)  Israeli Bobsled team Robbed (Fox) → Clip: Milan protests are intense → Clip: more protest footage AP gives no reason for riots at Olympics (AP) → DHS post, sent ICE agents to Italy for Olympics, quotes Variety (X)  Suspected saboteurs hit Italian rail network near Bologna, police say (CBC)   EPSTEIN 1:33:28 Note: France former culture minister resigns over Epstein (AP) Cclip: Ro Khana on the destruction of the royal family (cnn)  'Evil': Conservatives ERUPT on Steve Bannon Over Epstein Revelations (MediaIte) Epic Games denies rumors about presence of Jeffrey Epstein alive and playing Fortnite (MSN) Epstein heavily involved in "Micro-transactions" in video games Epstein WoW account and money laundering (IBT)   -Epstein Reportedly Ordered Multiple 55-Gallon Sulfuric Acid in 2018: 'Likely Used to Dissolve Bodies of Children' (IBT) → 330-Gallon Sulfuric Acid Purchase in 2018 Sparks Speculation (Criminal Watch) → He ordered 6x55 gallons which = 330 (X)   SCIENCE IS TRUTH 2:26:33 1-CRISPR removes chromosome to cure Down syndrome (Time of India) → Innovative Approach Developed for Removing Extra Chromosome 21 in Cells from Individuals with Down Syndrome Using CRISPR-Cas9 Genome Editing Technology (MIE) 2-First human trials of locally-developed HIV jab begin in South Africa (Yahoo/Telegraph) 3-Mexican Researchers Breakthrough That Could Lead to Complete Elimination of HPV (I24)   CANCER 2:30:55 4-Spanish scientists cure pancreatic cancer in mice in medical breakthrough (Fox) 5-Korean Scientists Reversed Colon Cancer Cells to Normal State (Open Gate Media) 6-Precision conversion of colorectal cancer lung metastases (NIH) 7-Russia unveils first test batches of cancer vaccine (RT) 8-Scientists discover 'levitating' time crystals that you can hold in your hand (Phys.org) 9-New type of magnetism discovered in 2D materials (Phys.org) Clip: Uncles Tremble as Man Invents Vaccine Delivered by Beer (Futurism)   GATES OF THE GODS/SPACE 2:39:29 *Scientists Say Heck, Just Nuke a Killer Asteroid Heading for Earth (Futurism)   EXECUTIVE PRODUCERS 2:47:57 TALENT/TIME 3:00:25 END 3:12:08

In Venezuela, families of political prisoners have been rallying outside the Supreme Court in Caracas, chanting for the release of their loved ones. Lawmakers in the country have approved the first step of an amnesty bill introduced by the interim leader, Delcy Rodríguez, in a move towards freeing hundreds of opposition politicians, journalists and human rights activists detained under previous governments. Also: scandal in Norway as police launch corruption investigation into the former Prime Minister Thorbjørn Jagland's ties to the late sex offender Jeffrey Epstein. Scientists in China find a potential alternative to conventional cervical cancer tests. We find out how South Africa's fight against HIV has been affected by the sweeping cuts to the United States foreign aid programme. Finland becomes the latest country to adopt a priority traffic system, allowing lights to turn green for emergency vehicles. How a previously unknown Michelangelo drawing became an auction sensation. And - why ski jumpers are being accused of a very unusual form of cheating in the run-up to the Winter Olympics.The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.ukPhoto credit: Ronald Pena